# Spironolactone and Hydrochlorothiazide

NDC: 0378-0403
Generic name: spironolactone and hydrochlorothiazide
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 19790803

FDA application: ANDA086513

## Active ingredients

- HYDROCHLOROTHIAZIDE: 25 mg/1
- SPIRONOLACTONE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-0403"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-0403
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0c8c973f-13a2-4883-8316-4006398e2931